Cargando…
Targeting Microglial Population Dynamics in Alzheimer’s Disease: Are We Ready for a Potential Impact on Immune Function?
Alzheimer’s disease (AD) is the most common form of dementia, affecting two-thirds of people with dementia in the world. To date, no disease-modifying treatments are available to stop or delay the progression of AD. This chronic neurodegenerative disease is dominated by a strong innate immune respon...
Autores principales: | Martin-Estebane, Maria, Gomez-Nicola, Diego |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289918/ https://www.ncbi.nlm.nih.gov/pubmed/32581720 http://dx.doi.org/10.3389/fncel.2020.00149 |
Ejemplares similares
-
Microglial Immunometabolism in Alzheimer’s Disease
por: Shippy, Daniel C., et al.
Publicado: (2020) -
Astroglial and microglial pathology in Down syndrome: Focus on Alzheimer's disease
por: García, Octavio, et al.
Publicado: (2022) -
Pharmacological Targeting of CSF1R Inhibits Microglial Proliferation and Aggravates the Progression of Cerebral Ischemic Pathology
por: Hou, Boru, et al.
Publicado: (2020) -
Phosphoinositides: Roles in the Development of Microglial-Mediated Neuroinflammation and Neurodegeneration
por: Ernest James Phillips, Thomas, et al.
Publicado: (2021) -
Modulating Microglial Cells for Promoting Brain Recovery and Repair
por: Hermann, Dirk M., et al.
Publicado: (2021)